Microbe Biosolutions Aps Financials, key figures and credit report
Gross profit - 749.8 kDKK FY 2025 -146.5% vs 2024
EBIT -2 677.8 kDKK FY 2025 -2,129.8% vs 2024
Net debt 2 570.2 kDKK FY 2025 -13.8% vs 2024
Quick ratio 0.8 FY 2025 +0.5 vs 2024
Income statement (kDKK)
2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | 535.97 | 1 163.25 | 1 613.12 | - 749.84 |
| Employee benefit expenses | - 575.89 | -1 014.52 | -1 185.19 | -1 483.00 |
| Total depreciation | -16.00 | -16.00 | - 296.00 | - 444.91 |
| EBIT | -55.92 | 132.73 | 131.92 | -2 677.75 |
| Other financial income | 0.00 | 1.62 | 9.57 | 0.84 |
| Other financial expenses | -28.82 | -56.02 | - 136.37 | - 184.69 |
| Pre-tax profit | -84.73 | 78.34 | 5.12 | -2 861.59 |
| Income taxes | 38.00 | -5.00 | 15.00 | 626.00 |
| Net earnings | -46.73 | 73.34 | 20.12 | -2 235.59 |
Assets (kDKK)
2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Development expenditure | 372.37 | 1 057.16 | 1 742.30 | 1 687.49 |
| Goodwill | 144.21 | 128.21 | 112.21 | 96.21 |
| Intangible assets total | 516.57 | 1 185.37 | 1 854.51 | 1 783.70 |
| Tangible assets total | ||||
| Investments total | 39.14 | |||
| Long term receivables total | ||||
| Raw materials and consumables | 344.83 | 510.13 | 1 699.60 | 806.59 |
| Inventories total | 344.83 | 510.13 | 1 699.60 | 806.59 |
| Current trade debtors | 1 143.14 | 370.26 | 677.68 | 354.94 |
| Current amounts owed by group member comp. | 15.35 | |||
| Prepayments and accrued income | 9.40 | 8.71 | 15.06 | 5.86 |
| Current other receivables | 12.18 | 146.67 | 91.06 | |
| Current deferred tax assets | 38.00 | 33.00 | 48.00 | 674.00 |
| Short term receivables total | 1 202.72 | 411.97 | 902.76 | 1 125.85 |
| Cash and bank deposits | 0.74 | 500.07 | 501.20 | 787.66 |
| Cash and cash equivalents | 0.74 | 500.07 | 501.20 | 787.66 |
| Balance sheet total (assets) | 2 103.99 | 2 607.53 | 4 958.08 | 4 503.81 |
Equity and liabilities (kDKK)
2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Share capital | 400.00 | 400.00 | 400.00 | 400.00 |
| Other reserves | 290.44 | 824.58 | 1 359.00 | 1 316.24 |
| Retained earnings | - 290.44 | - 871.32 | -1 332.39 | -1 269.51 |
| Profit of the financial year | -46.73 | 73.34 | 20.12 | -2 235.59 |
| Shareholders equity total | 353.27 | 426.61 | 446.73 | -1 788.87 |
| Capital loans | 3 344.15 | |||
| Non-current other liabilities | 505.89 | 573.48 | 636.26 | |
| Non-current liabilities total | 505.89 | 573.48 | 3 980.41 | |
| Current loans from credit institutions | 368.50 | 304.30 | 13.69 | |
| Current trade creditors | 116.48 | 125.33 | 380.06 | 2 021.14 |
| Current owed to participating | 110.57 | 116.22 | 1 769.29 | |
| Current owed to group member | 712.85 | 907.39 | 1 408.38 | |
| Other non-interest bearing current liabilities | 226.28 | 157.59 | 75.83 | 277.43 |
| Accruals and deferred income | 584.54 | |||
| Current liabilities total | 1 750.73 | 1 675.04 | 3 937.87 | 2 312.26 |
| Balance sheet total (liabilities) | 2 103.99 | 2 607.53 | 4 958.08 | 4 503.81 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated